1. Home
  2. CLNNW

CLNNW

Clene Inc. Warrant

Logo Clene Inc. Warrant

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 03-13-2024 2:06pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

Founded: N/A Country:
United States
United States
Employees: 85 City: SALT LAKE CITY
Market Cap: N/A IPO Year: N/A
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: